Inmazeb.com

Keyword Suggestion

Inmazeb and ebanga

Inmazeb

Inmazeb ebola

Inmazeb structure

Inmazeb approval

Inmazeb ema

Inmazeb cost

Inmazeb regeneron

Inmazeb fda

Inmazeb uspi

Inmazeb mechanism of action

Inmazeb medicine

Inmazeb prescribing information

Domain Informations

Whois Informations
Top 10 Domain Provider

Inmazeb.com lookup results from whois.markmonitor.com server:

Network

Owner

Technical support

Abuse

Domain Provider	Number Of Domains
godaddy.com	286730
namecheap.com	101387
networksolutions.com	69118
tucows.com	52617
publicdomainregistry.com	39120
whois.godaddy.com	32793
enomdomains.com	23825
namesilo.com	21429
domains.google.com	21384
cloudflare.com	20573
gmo.jp	18110
name.com	17601
fastdomain.com	14708
register.com	13495
net.cn	12481
ionos.com	12416
ovh.com	12416
gandi.net	12305
registrar.amazon.com	12111

Host Informations

Check all domain's dns records

See Web Sites Hosted on 104.18.38.185

Fetching Web Sites Hosted

Site Inspections

Port Scanner (IP: 104.18.38.185)

› Ftp: 21

› Ssh: 22

› Telnet: 23

› Smtp: 25

› Dns: 53

› Http: 80

› Pop3: 110

› Portmapper, rpcbind: 111

› Microsoft RPC services: 135

› Netbios: 139

› Imap: 143

› Ldap: 389

› Https: 443

› SMB directly over IP: 445

› Msa-outlook: 587

› IIS, NFS, or listener RFS remote_file_sharing: 1025

› Lotus notes: 1352

› Sql server: 1433

› Point-to-point tunnelling protocol: 1723

› My sql: 3306

› Remote desktop: 3389

› Session Initiation Protocol (SIP): 5060

› Virtual Network Computer display: 5900

› X Window server: 6001

› Webcache: 8080

Spam Check (IP: 104.18.38.185)

› Dnsbl-1.uceprotect.net:

› Dnsbl-2.uceprotect.net:

› Dnsbl-3.uceprotect.net:

› Dnsbl.dronebl.org:

› Dnsbl.sorbs.net:

› Spam.dnsbl.sorbs.net:

› Bl.spamcop.net:

› Recent.dnsbl.sorbs.net:

› All.spamrats.com:

› B.barracudacentral.org:

› Bl.blocklist.de:

› Bl.emailbasura.org:

› Bl.mailspike.org:

› Bl.spamcop.net:

› Cblplus.anti-spam.org.cn:

› Dnsbl.anticaptcha.net:

› Ip.v4bl.org:

› Fnrbl.fast.net:

› Dnsrbl.swinog.ch:

› Mail-abuse.blacklist.jippg.org:

› Singlebl.spamgrouper.com:

› Spam.abuse.ch:

› Spamsources.fabel.dk:

› Virbl.dnsbl.bit.nl:

› Cbl.abuseat.org:

› Dnsbl.justspam.org:

› Zen.spamhaus.org:

Email address with inmazeb.com

Found 0 emails of this domain

Recent Searched Sites

› 1xstavka.ru (4 seconds ago) / RU

› Sxshyy.com.cn (0 seconds ago) / JP

› Tornboot.ru (1 seconds ago) / RU

› Genomapp.com (53 seconds ago) / ES

› Jszhaosheng.com (11 seconds ago) / HK

› Medpracticesuccess.com (2 seconds ago) / US

› Mcdonalds.com.lb (10 seconds ago) / NL

› Evhp.net (3 seconds ago) / US

› Spencercashsaver.com (1 mins ago) / US

› Lenard.tech (31 seconds ago) / ES

› Myflfamilies.com (19 seconds ago) / US

› Repliancepro.com (4 seconds ago) / US

› Gib.com (9 seconds ago) / US

› Reportsvideosf.blogspot.com (0 seconds ago) / US

› Mameguide.info (4 seconds ago) / AU

› Inmazeb.com (0 seconds ago) / US

› Leelaq.com (1 mins ago) / US

› Castlecraig.co.uk (23 seconds ago) / US

› Amoruadesserts.com (56 seconds ago) / CO

› Codersfree.com (13 seconds ago) / US

List of our tools

Emails by domain

Mobile Friendly Check

Page Speed Check

DNS Lookup

Ports Scan

Sites on host

Sitemap Generator

Websites Listing

We found Websites Listing below when search with inmazeb.com on Search Engine

Zaire Ebolavirus Treatment | Inmazeb™

The efficacy of Inmazeb has not been established for other species of the Ebolavirus and Marburgvirus genera. Zaire ebolavirus can change over time, and factors such as emergence of resistance, or changes in viral virulence could …

Inmazeb.com

三抗体鸡尾酒疗法新药：Inmazeb（REGN-EB3）治疗埃博拉病毒感 …

Inmazeb（atoltivimab、maftivimab、odesivimab-ebgn，前称REGN-EB3）【生产企业】：再生元（Regeneron）【规格】：Inmazeb是透明到微乳白色、无色到淡黄色的溶液，供注射用：每支单剂量药瓶为14.5mL含241.7mg atoltivimab, 241.7mg maftivimab和 241.7mg odesivimab-ebgn。

Zhuanlan.zhihu.com

Regeneron’s Inmazeb gets FDA approval for Ebola treatment

The three antibodies that constitute Inmazeb can simultaneously attach to the glycoprotein and prevent attachment and entry of the virus. The FDA approval for Inmazeb was based on the findings of the PALM trial, which was a randomised, multicentre, controlled study launched in 2018 in the Democratic Republic of Congo. The trial, which ...

Pharmaceutical-business-review.com

Regeneron gets FDA approval for Inmazeb as first treatment ...

2020-10-15 · Inmazeb is administered as a single intravenous infusion, based on the weight of the patient, in a proportion of 50mg atoltivimab, 50mg maftivimab and 50mg odesivimab per kg weight. Regeneron president and chief scientific officer Dr. George Yancopoulos said: “We are incredibly proud that the FDA has approved Inmazeb, which is also known as REGN-EB3. …

Ns-healthcare.com

Inmazeb - Abstract - Europe PMC

Share this article Share with email Share with twitter Share with linkedin Share with facebook. Abstract . Inmazeb is a mixture of monoclonal antibodies, atoltivimab, maftivimab, and odesivimab that are directed against Zaire ebolavirus glycoprotein. No information is available on the use of Inmazeb during breastfeeding. Because Inmazeb is a mixture of large protein …

Europepmc.org

Inmazeb Clinical Development Timeline :: Pink Sheet

Please enter a valid e-mail address Please make sure you have filled out all fields Please make sure you have filled out all fields Subject: Inmazeb Clinical Development Timeline Add a personalized message to your email. Cancel. Send. Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the …

Pink.pharmaintelligence.informa.com

FDA approves antibody cocktail for Ebola virus - Nature

2020-11-03 · FDA approves antibody cocktail for Ebola virus. The FDA has approved Regeneron’s Inmazeb — a mixture of three monoclonal antibodies — for Ebola virus. This is the first FDA-approved ...

Nature.com

First Treatment for Ebola Virus Gets FDA Approval - MPR

2020-10-15 · Inmazeb will be supplied as a preservative-free solution containing 241.7mg of atoltivimab, 241.7mg of maftivimab, and 241.7mg of odesivimab-ebgn …

Empr.com

TEAS RF New Application for Inmazeb

*email address: [email protected] *authorized to communicate via email: yes: fee information; application filing option: teas rf: number of classes: 1: application for registration per class: 275 *total fee due: 275 *total fee paid: 275: signature information; signature /ogrp-cnr-tjm-jjs/ signatory's name: terrence j. mcallister: signatory's ...

Uspto.report

Medikament gegen Ebola: „Inmazeb“ als erstes Mittel in den ...

Das zugelassene Medikament Inmazeb war eines von vier Kandidaten, die während eines Ebolaausbruchs im Kongo getestet wurden, durch den bis zu seinem Ende im Juni beinahe 2300 Menschen ums Leben kamen. Unter den Studienteilnehmer lag die Überlebensrate bei Patienten, die Inmazeb oder ein anderes experimentelles Medikament bekamen, deutlich höher. Die …

Rnd.de

Inmazeb Brought Regeneron A Priority Review Voucher, But ...

Please enter a valid e-mail address Please make sure you have filled out all fields Please make sure you have filled out all fields Subject: Inmazeb Brought Regeneron A Priority Review Voucher, But Not The Type It Wanted Add a personalized message to your email. Cancel. Send. Please Note: Only individuals with an active subscription will be able to access the full article. …

Pink.pharmaintelligence.informa.com

FDA: Approves First Treatment for Ebola ... - FDA Health News

2020-10-16 · In the PALM trial, the safety and efficacy of Inmazeb was evaluated in a multi-center, open-label, randomized controlled trial, in which 154 patients received Inmazeb (50 mg of each monoclonal antibody) intravenously as a single infusion, and 168 patients received an investigational control. The primary efficacy endpoint was 28-day mortality. The primary …

Fdahealthnews.com

Regeneron's Inmazeb Approval For Ebola Paves The Way In ...

2020-10-15 · Please enter a valid e-mail address Please make sure you have filled out all fields Please make sure you have filled out all fields Subject: Regeneron's Inmazeb Approval For Ebola Paves The Way In COVID-19 Add a personalized message to your email. Cancel. Send. Please Note: Only individuals with an active subscription will be able to access the full article. All other …

Scrip.pharmaintelligence.informa.com

伊波拉病毒有解藥了？FDA 核准全球第一個療法！ | GeneOnline …

2020-10-15 · Inmazeb 未來應用 . Regeneron 未來將在 6 年內提供美國衞生部轄下生物醫學高級研究和發展局（Biomedical Advanced Research and Development Authority, BARDA）定數的 Inmazeb 療程劑量，並且提供剛果民主共和國患者恩慈療法（compassionate use）以抑制伊波拉病毒疫情。未來 Regeneron 將與非政府組織（non-governmental organization ...

Geneonline.news

How to pronounce inmazeb | HowToPronounce.com

2022-03-16 · 3 /5. (12 votes) Very easy. Easy. Moderate. Difficult. Very difficult. Thanks for your vote! Pronunciation of inmazeb with 1 audio pronunciations.

Howtopronounce.com

Developing Plant-Based Vaccines and Therapeutics for COVID ...

2022-03-03 · Email Address* Country* Company Type ... Inmazeb is a combination of three monoclonal antibodies that simultaneously bind to the virus glycoprotein. A vaccine that protects against the most lethal species of ebolavirus has been approved for use in the US. Middle East respiratory syndrome (MERS) is caused by a coronavirus infection and was first reported in …

Technologynetworks.com

First Ebola therapy approved by the FDA - STAT

2020-10-14 · Inmazeb, which is made up of three monoclonal antibodies, was shown to be effective in treating the Zaire strain of Ebola in a clinical trial conducted during the 2018-2020 North Kivu outbreak in ...

Statnews.com

Web Edition - dva.sanfordguide.com

New user? If you do not have an account here, head over to the registration form.

Dva.sanfordguide.com

Page 58 of 64 — Venable Fitzpatrick's BiologicsHQ

[email protected] FDA Guidance (Biologics) FDA Guidance (Biosimilars) FDA Industry Info and Guidance (Biosimilars) Federal Circuit Opinions; USPTO MPEP; USPTO Patent Search; USPTO PTAB Portal; USPTO Search PTAB; Subscribe; Select Page. Inmazeb. by April Breyer Menon | Apr 4, 2022 | Uncategorized. INMAZEB (atoltivimab; odesivimab; maftivimab) is a combination …

Biologicshq.com

Ιός του Έμπολα: Εγκρίθηκε η πρώτη θεραπεία – Πως δρα το ...

2020-10-15 · Ο Αμερικανικός Οργανισμός Φαρμάκων, ενέκρινε την πρώτη θεραπεία για τον ιό του Έμπολα, με τον οποίο παρουσιάζεται αιμορραγικός πυρετός. Συγκεκριμένα, πρόκειται για το φάρμακο Inmazeb. Το πρώτο φάρμακο για την ...

Pronews.gr

Domains Expiration Date Updated

Site	Provider	Expiration Date
equatorise.com	hostinger.com	-2 Years, -81 Days
ebulmaca.net	publicdomainregistry.com	-2 Years, -107 Days
egpres.com	godaddy.com	-2 Years, -215 Days
kidd.co	wildwestdomains.com	-2 Years, -61 Days
biltmorecardiology.com	networksolutions.com	143 Days
jukutown.com	gmo.jp	161 Days
yardteam.org	reg.com	-2 Years, -206 Days
situsnobar.com	namecheap.com	-2 Years, -86 Days
devominer.com	namecheap.com	-1 Years, -300 Days
eluxura.com	godaddy.com	-1 Years, -52 Days

Browser All